Exogenous Aspergillus niger endophthalmitis in a patient with a filtering bleb.
Krzystolik
M G
MG
Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston, USA.
Ciulla
T A
TA
Topping
T M
TM
Baker
A S
AS
D000368:Aged; D000666:Amphotericin B / Q000008:administration & dosage / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D001228:Aspergillosis / Q000188:drug therapy / Q000209:etiology*; D001234:Aspergillus niger / Q000302:isolation & purification*; D009877:Endophthalmitis / Q000188:drug therapy / Q000382:microbiology*; D015821:Eye Infections, Fungal / Q000188:drug therapy / Q000209:etiology*; D005902:Glaucoma, Open-Angle / Q000601:surgery; D006801:Humans; D017964:Itraconazole / Q000627:therapeutic use; D007903:Lens Capsule, Crystalline / Q000382:microbiology; D008297:Male; D009883:Ophthalmic Solutions; D018918:Phacoemulsification / Q000009:adverse effects*; D014130:Trabeculectomy; D014792:Visual Acuity
D000935:Antifungal Agents; D009883:Ophthalmic Solutions; D017964:Itraconazole; D000666:Amphotericin B